Published 2 years ago
Interview ZACARIAH L HILDENBRAND, PH.D. C4 LABORATORIES
Dr. Zacariah L. Hildenbrand, Ph. D.
Chief Scientific Officer / Co-Owner
Dr. Zacariah L. Hildenbrand received his Bachelors of Science and Ph.D. degrees from the University of Texas at El Paso, where he also played on the men’s intercollegiate golf team. Dr. Hildenbrand’s doctoral research focused on the molecular architecture involved in hormone-dependent cancers and was awarded the best doctoral dissertation in the College of Science for the year 2010. Dr. Hildenbrand continued his training as a post-doctoral research fellow at the University of Texas Southwestern Medical Center in Dallas where he worked on a therapy for the treatment of chronic myeloid leukemia; a blood-borne cancer that afflicts small children.
Throughout his experiences in science and in business, Dr. Hildenbrand has published more than 20 peer-reviewed scientific journal articles and textbook chapters, has presented his research throughout North and South America, and has built his consultancy into one of the most recognizable firms in the state of Texas. Now as the Chief Scientific Officer for C4 Laboratories, Dr. Hildenbrand is focused on educating the general public about the scientific merits of compassionate cannabis, as well as developing new innovations for cannabis-based therapies. Dr. Hildenbrand enjoys new research challenges that carry deep social significance and is driven to provide solutions and find more efficient treatments for those struggling with illness.